Yun-Fei Xia

2.0k total citations
40 papers, 1.2k citations indexed

About

Yun-Fei Xia is a scholar working on Oncology, Otorhinolaryngology and Molecular Biology. According to data from OpenAlex, Yun-Fei Xia has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Otorhinolaryngology and 10 papers in Molecular Biology. Recurrent topics in Yun-Fei Xia's work include Head and Neck Cancer Studies (19 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Viral-associated cancers and disorders (5 papers). Yun-Fei Xia is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Viral-associated cancers and disorders (5 papers). Yun-Fei Xia collaborates with scholars based in China, United States and Hong Kong. Yun-Fei Xia's co-authors include Mu‐Sheng Zeng, Man-Zhi Li, Jin Gao, Lu-Jun Shen, Chen Chen, Hao-Yuan Mo, Wan-Li Liu, Jian‐Yong Shao, Wenting Liao and Liwu Fu and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Yun-Fei Xia

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun-Fei Xia China 21 508 461 364 277 213 40 1.2k
Cheng–Lung Hsu Taiwan 17 284 0.6× 307 0.7× 291 0.8× 130 0.5× 204 1.0× 33 1.2k
Cheng‐Lung Hsu Taiwan 18 364 0.7× 187 0.4× 348 1.0× 147 0.5× 178 0.8× 46 881
Gang Peng China 16 275 0.5× 472 1.0× 429 1.2× 328 1.2× 279 1.3× 44 1.2k
Yasuo Ejima Japan 20 379 0.7× 332 0.7× 105 0.3× 215 0.8× 205 1.0× 49 1.3k
Kara Hamilton United States 10 206 0.4× 371 0.8× 95 0.3× 354 1.3× 136 0.6× 14 945
J. L. Formento France 12 481 0.9× 306 0.7× 154 0.4× 142 0.5× 93 0.4× 19 851
Kichinobu Tomita Japan 13 459 0.9× 249 0.5× 147 0.4× 113 0.4× 377 1.8× 36 943
Fuxiang Zhou China 20 454 0.9× 540 1.2× 52 0.1× 275 1.0× 129 0.6× 85 1.2k
Muh‐Hwa Yang Taiwan 16 456 0.9× 465 1.0× 63 0.2× 245 0.9× 158 0.7× 56 1.3k
Hening Ren United States 15 257 0.5× 621 1.3× 115 0.3× 227 0.8× 99 0.5× 21 976

Countries citing papers authored by Yun-Fei Xia

Since Specialization
Citations

This map shows the geographic impact of Yun-Fei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun-Fei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun-Fei Xia more than expected).

Fields of papers citing papers by Yun-Fei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun-Fei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun-Fei Xia. The network helps show where Yun-Fei Xia may publish in the future.

Co-authorship network of co-authors of Yun-Fei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yun-Fei Xia. A scholar is included among the top collaborators of Yun-Fei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun-Fei Xia. Yun-Fei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chen, Hao Jiang, Jin Gao, et al.. (2018). A Prognostic Score for Nasopharyngeal Carcinoma with Bone Metastasis: Development and Validation from Multicenter. Journal of Cancer. 9(5). 797–806. 13 indexed citations
2.
Xiao, Wei, Jing Zhao, Man-Zhi Li, et al.. (2017). EDB Fibronectin-Specific SPECT Probe 99mTc-HYNIC-ZD2 for Breast Cancer Detection. ACS Omega. 2(6). 2459–2468. 15 indexed citations
3.
4.
Cui, Qian, Qi-Sheng Feng, Yun-Fei Xia, et al.. (2016). Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis. Tumor Biology. 37(11). 14825–14830. 6 indexed citations
5.
Wei, Yi, et al.. (2016). CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma. OncoTargets and Therapy. Volume 9. 7011–7017. 9 indexed citations
6.
Zhong, Qian, Qi Chen, Mei-Yin Zhang, et al.. (2016). RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma. Cell Death and Disease. 7(9). e2352–e2352. 55 indexed citations
7.
Cui, Qian, Qi-Sheng Feng, Hao-Yuan Mo, et al.. (2016). An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. Human Molecular Genetics. 25(16). 3626–3634. 30 indexed citations
8.
Wang, Han‐Yu, et al.. (2015). Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma. Asian Pacific Journal of Cancer Prevention. 16(9). 3741–3745. 16 indexed citations
9.
Shen, Lu-Jun, Si-Yang Wang, Qi Zeng, et al.. (2015). Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system. Chinese Journal of Cancer. 34(3). 450–8. 47 indexed citations
10.
Feng, Guo‐Kai, Qian Zhong, Yun-Fei Xia, et al.. (2014). SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide. Journal of Controlled Release. 192. 236–242. 32 indexed citations
11.
Chen, Chen, et al.. (2013). Smoking is a poor prognostic factor for male nasopharyngeal carcinoma treated with radiotherapy. Radiotherapy and Oncology. 110(3). 409–415. 26 indexed citations
12.
Guo, Li, et al.. (2012). Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chinese Journal of Cancer. 31(4). 197–206. 69 indexed citations
14.
Gao, Jin, Hongyan Zhang, & Yun-Fei Xia. (2012). Increased platelet count is an indicator of metastasis in patients with nasopharyngeal carcinoma. Tumor Biology. 34(1). 39–45. 27 indexed citations
15.
Gao, Jin, et al.. (2011). Involvement of Difference in Decrease of Hemoglobin Level in Poor Prognosis of Stage I and II Nasopharyngeal Carcinoma: Implication in Outcome of Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1471–1478. 27 indexed citations
16.
Liu, Li, Li-Hua Xu, Yi Wei, et al.. (2011). Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Oncology Reports. 27(4). 1116–1122. 31 indexed citations
18.
Wu, Yong, Wei-Han Hu, Yun-Fei Xia, et al.. (2006). Quality of life of nasopharyngeal carcinoma survivors in Mainland China. Quality of Life Research. 16(1). 65–74. 32 indexed citations
19.
Ma, Jun, et al.. (2005). Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiotherapy and Oncology. 75(2). 197–203. 30 indexed citations
20.
Zhou, Jun-Min, et al.. (2004). Aloe Polysaccharides Mediated Radioprotective Effect through the Inhibition of Apoptosis. Journal of Radiation Research. 45(3). 447–454. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026